Apogee Therapeutics, Inc. APGE Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s total liabilities & equity?
- Apogee Therapeutics, Inc. (APGE) reported total liabilities & equity of $1.29B in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Apogee Therapeutics, Inc.'s total liabilities & equity increased by 81.1% year-over-year, from $714.16M to $1.29B.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total liabilities & equity?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s total liabilities & equity has grown at a 83.3% compound annual growth rate (CAGR), from $152.06M to $937.13M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.